arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

CARDINAL HEALTH INC

CAH
$267.90 ▲ +5.92 (+2.26%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
72 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Bearish
auto_awesome

Analytical Summary

CARDINAL HEALTH INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC None
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$65.63B
↑ +18.8% —
Net Income Profit after all expenses
$467.00M
↑ +16.8% —
Operating Margin Operating profit as % of sales
1.1%
↑ +3.2% 29th
FCF / Share Free cash flow per share
$2.35
↓ -35.3% —
Long-Term Debt Long-term obligations
$2.48B
↓ -7.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
28
Returns
12
Financial Health
72
Cash Quality
90

Dividend History

Dividend / share · sourced from SEC filings
$2.04 Latest / share
+1.0% YoY
+3.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 19 years · 72 quarters